Lisa K. Layman
“In policy efforts with legislators, regulators, or their staffs, you need to not only understand what matters to your client, but you also need to understand what matters to the people you’re speaking with. It’s by addressing their concerns and explaining how your client’s goals and their goals align that you get the process moving in the right direction.”
Lisa Layman brings decades of health care policy experience on Capitol Hill, having worked for legislators and alongside health care constituencies to advance legislative and regulatory objectives across the health policy landscape. Her deep substantive knowledge, strategic judgment, and candor have made her a trusted resource for lawmakers, staff, and regulators of both parties and an effective advocate for her clients.
Lisa represents providers, manufacturers, associations, and other health care industry stakeholders before Congress and the Executive Branch. She pairs her policy expertise with practical insights gained from years in the legislative trenches—knowing who to engage, when to engage them, what resonates, and how to frame solutions that align client objectives with policymaker priorities. In addition to her advocacy work, Lisa advises clients on broader public policy goals and specific business needs.
Before entering private government relations practice, Lisa served for 11 years as legislative staff in the U.S. Senate. She was a senior policy advisor to U.S. Senator Debbie Stabenow and previously advised Senators Bob Graham, Richard Bryan, and John Chafee on health care matters. In these roles, she drafted, analyzed, and negotiated legislation related to Medicare, Medicaid, and private health insurance, prescription drugs, health information technology, and public health. Earlier in her career, Lisa worked at the Congressional Budget Office, where she prepared baseline projections and legislative cost estimates for health care proposals.
After leaving the Senate, Lisa served as Vice President for Government Affairs at the Generic Pharmaceutical Association (now the Association for Accessible Medicines), where she worked closely with senior executives to develop and execute comprehensive public policy and lobbying strategies.
